Broadpoint Upgrades Verenium (VRNM) to Buy

August 6, 2008 10:32 AM EDT

Broadpoint Capital upgrades Verenium (Nasdaq: VRNM) from Neutral to Buy.

Verenium Corporation, together with its subsidiaries, engages in the development and production of specialty enzyme products, and production and commercialization of biofuels.


Related Categories

Upgrades

Stocks Mentioned

VRNM 4.37

+0.03 +0.69%
Volume: 36,166
Track VRNM


Related Entities


Add Your Comment